Discovery and validation of biomarkers that distinguish mucinous and nonmucinous pancreatic cysts

Cancer Research

Volumn 75, Issue 16, 2015, Pages 3227-3235

  Park, Jisook ^a   Yun, Hwan Sic ^b   Lee, Kwang Hyuck ^b   Lee, Kyu Taek ^b   Lee, Jong Kyun ^b   Lee, Soo Youn ^a,b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLASE; BINDING PROTEIN; BIOLOGICAL MARKER; CHYMOTRYPSIN; GALACTOSIDE; IMMUNOGLOBULIN FC FRAGMENT; LECTIN; LITHOSTATHINE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SECRETORY COMPONENT; PROTEOME; TUMOR MARKER;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MUCINOUS PANCREATIC CYST; NANOANALYSIS; NONMUCINOUS PANCREATIC CYST; PANCREAS CYST; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BINDING; PROTEIN EXPRESSION; PSEUDOCYST; RADIOIMMUNOASSAY; TANDEM MASS SPECTROMETRY; VALIDATION PROCESS; METABOLISM; MIDDLE AGED; PANCREATIC CYST; PANCREATIC NEOPLASMS; PROCEDURES; PROTEOMICS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CHROMATOGRAPHY, LIQUID; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PANCREATIC CYST; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84942879439     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-2896     Document Type: Article

References (31)

1. Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol 2010;105:2079-84.
2. de Jong K, Nio CY, Hermans JJ, Dijkgraaf MG, Gouma DJ, van Eijck CH, et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 2010; 8:806-11.
3. Laffan TA, Horton KM, Klein AP, Berlanstein B, Siegelman SS, Kawamoto S, et al. Prevalence of unsuspected pancreatic cysts on MDCT. AJR Am J Roentgenol 2008;191:802-7.
4. Girometti R, Intini S, Brondani G, Como G, Londero F, Bresadola F, et al. Incidental pancreatic cysts on 3D turbo spin echo magnetic resonance cholangiopancreatography: prevalence and relationwith clinical and imaging features. Abdom Imaging 2011;36:196-205.
5. Brugge WR, Lewandrowski K, Lee-Lewandrowski E, Centeno BA, Szydlo T, Regan S, et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004;126: 1330-6.
6. Krieg RC, Paweletz CP, Liotta LA, Petricoin EF III. Clinical proteomics for cancer biomarker discovery and therapeutic targeting. Technol Cancer Res Treat 2002;1:263-72.
7. Liang S, Xu Z, Xu X, Zhao X, Huang C, Wei Y. Quantitative proteomics for cancer biomarker discovery. Comb Chem High Throughput Screen 2012; 15:221-31.
8. Liu NQ, Braakman RB, Stingl C, Luider TM, Martens JW, Foekens JA, et al. Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue. J Mammary Gland Biol Neoplasia 2012;17:155-64.
9. Lu M, Faull KF, Whitelegge JP, He J, Shen D, Saxton RE, et al. Proteomics and mass spectrometry for cancer biomarker discovery. Biomark Insights 2007;2:347-60.
10. Haab BB, Porter A, Yue T, Li L, Scheiman J, Anderson MA, et al. Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann Surg 2010; 251:937-45.
11. Ke E, Patel BB, Liu T, Li XM, Haluszka O, Hoffman JP, et al. Proteomic analyses of pancreatic cyst fluids. Pancreas 2009;38:e33-42.
12. Scarlett CJ, Samra JS, Xue A, Baxter RC, Smith RC. Classification of pancreatic cystic lesions using SELDI-TOF mass spectrometry. ANZ J Surg 2007;77:648-53.
13. Cuoghi A, Farina A, Z'Graggen K, Dumonceau JM, Tomasi A, Hochstrasser DF, et al. Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts. J Proteome Res 2011;10:2664-70.
14. Jabbar KS, Verbeke C, Hyltander AG, Sjovall H, Hansson GC, Sadik R. Proteomic mucin profiling for the identification of cystic precursors of pancreatic cancer. J Natl Cancer Inst 2014;106:djt439.
15. Mann BF, Goetz JA, House MG, Schmidt CM, Novotny MV. Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins. Mol Cell Proteomics 2012;11:M111.015792.
16. Old WM, Meyer-Arendt K, Aveline-Wolf L, Pierce KG, Mendoza A, Sevinsky JR, et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 2005; 4:1487-502.
17. Shen J, Brugge WR, Dimaio CJ, Pitman MB. Molecular analysis of pancreatic cyst fluid: a comparative analysis with current practice of diagnosis. Cancer 2009;117:217-27.
18. Cizginer S, Turner BG, Bilge AR, Karaca C, Pitman MB, Brugge WR. Cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. Pancreas 2011;40:1024-8.
19. Linder JD, Geenen JE, Catalano MF. Cyst fluid analysis obtained by EUSguided FNA in the evaluation of discrete cystic neoplasms of the pancreas: a prospective single-center experience. Gastrointest Endosc 2006;64:697-702.
20. Park WG, Mascarenhas R, Palaez-Luna M, Smyrk TC, O'Kane D, Clain JE, et al. Diagnostic performance of cyst fluid carcinoembryonic antigen and amylase in histologically confirmed pancreatic cysts. Pancreas 2011;40: 42-5.
21. Jackson D, Craven RA, Hutson RC, Graze I, Lueth P, Tonge RP, et al. Proteomic profiling identifies afamin as a potential biomarker for ovarian cancer. Clin Cancer Res 2007;13:7370-9.
22. Opstal-van Winden AW, Krop EJ, Karedal MH, Gast MC, Lindh CH, Jeppsson MC, et al. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study.BMC Cancer 2011;11:381.
23. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D. Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry. Cancer Res 2004; 64:9018-26.
24. Ai J, Tang Q, Wu Y, Xu Y, Feng T, Zhou R, et al. The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma. J Natl Cancer Inst 2011;103: 1696-712.
25. Ocak S, Pedchenko TV, Chen H,Harris FT,Qian J, Polosukhin V, et al. Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis. Eur Respir J 2012;39:1171-80.
26. Bauer M, Eickhoff JC, Gould MN, Mundhenke C, Maass N, Friedl A. Neutrophil gelatinase-associated lipocalin (NGAL) is a predictor of poor prognosis in human primary breast cancer. Breast Cancer Res Treat 2008;108:389-97.
27. Fernandez CA, Yan L, Louis G, Yang J, Kutok JL, Moses MA. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 2005; 11:5390-5.
28. Lim R, Ahmed N, Borregaard N, Riley C, Wafai R, Thompson EW, et al. Neutrophil gelatinase-associated lipocalin (NGAL) an early-screening biomarker for ovarian cancer: NGAL is associated with epidermal growth factor-induced epithelio-mesenchymal transition. Int J Cancer 2007;120: 2426-34.
29. Brand RE, Nolen BM, Zeh HJ, Allen PJ, Eloubeidi MA, Goldberg M, et al. Serum biomarker panels for the detection of pancreatic cancer. Clin Cancer Res 2011;17:805-16.
30. Moniaux N, Chakraborty S, Yalniz M, Gonzalez J, Shostrom VK, Standop J, et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. Br J Cancer 2008;98:1540-7.
31. Tong Z, Kunnumakkara AB, Wang H, Matsuo Y, Diagaradjane P, Harikumar KB, et al. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res 2008;68:6100-8.